Abstract
Many disease processes can be divided into three stages: the non-diseased stage: the early diseased stage, and the fully diseased stage. To assess the accuracy of diagnostic tests for such diseases, various summary indexes have been proposed, such as volume under the surface (VUS), partial volume under the surface (PVUS), and the sensitivity to the early diseased stage given specificity and the sensitivity to the fully diseased stage (P2). This paper focuses on confidence interval estimation for P2 based on empirical likelihood. Simulation studies are carried out to assess the performance of the new methods compared to the existing parametric and nonparametric ones. A real dataset from Alzheimers Disease Neuroimaging Initiative (ADNI) is analyzed.
| Original language | English |
|---|---|
| Pages (from-to) | 1215-1233 |
| Number of pages | 19 |
| Journal | Journal of Biopharmaceutical Statistics |
| Volume | 25 |
| Issue number | 6 |
| DOIs | |
| State | Published - Nov 2 2015 |
Keywords
- Diagnostic tests
- Empirical likelihood
- The sensitivity to the early diseased stage
Fingerprint
Dive into the research topics of 'Confidence Interval Estimation for Sensitivity to the Early Diseased Stage Based on Empirical Likelihood'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver